Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2001 1
2002 4
2003 7
2004 4
2005 5
2006 1
2007 3
2008 3
2009 5
2010 3
2011 5
2012 9
2013 13
2014 10
2015 5
2016 5
2017 4
2018 4
2019 5
2020 11
2021 29
2022 28
2023 17
2024 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Nakamori M, Nakatani D, Sato T, Hasuike Y, Kon S, Saito T, Nakamura H, Takahashi MP, Hida E, Komaki H, Matsumura T, Takada H, Mochizuki H. Nakamori M, et al. Among authors: nakatani d. EClinicalMedicine. 2023 Dec 26;67:102390. doi: 10.1016/j.eclinm.2023.102390. eCollection 2024 Jan. EClinicalMedicine. 2023. PMID: 38314057 Free PMC article.
Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction.
Sotomi Y, Tamaki S, Hikoso S, Nakatani D, Okada K, Dohi T, Sunaga A, Kida H, Sato T, Matsuoka Y, Sakamoto D, Kitamura T, Komukai S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Ohtani T, Yasumura Y, Yamada T, Sakata Y; OCVC-Heart Failure Investigators. Sotomi Y, et al. Among authors: nakatani d. Heart. 2024 Feb 23;110(6):441-447. doi: 10.1136/heartjnl-2023-323059. Heart. 2024. PMID: 37827559
Pediatric drug development in Japan: Current issues and perspectives.
Saitou H, Nakatani D, Myoui A, Kubota T, Ozono K. Saitou H, et al. Among authors: nakatani d. Clin Pediatr Endocrinol. 2020;29(1):1-7. doi: 10.1297/cpe.29.1. Epub 2020 Jan 9. Clin Pediatr Endocrinol. 2020. PMID: 32029968 Free PMC article. Review.
Low-density lipoprotein cholesterol, erythrocyte, and platelet in heart failure with preserved ejection fraction.
Yano M, Nishino M, Kawanami S, Ukita K, Kawamura A, Yasumoto K, Tsuda M, Okamoto N, Matsunaga-Lee Y, Egami Y, Yamada T, Yasumura Y, Seo M, Hayashi T, Nakagawa A, Nakagawa Y, Tamaki S, Sotomi Y, Nakatani D, Hikoso S, Sakata Y; Osaka CardioVascular Conference (OCVC)‐Heart Failure Investigators. Yano M, et al. Among authors: nakatani d. ESC Heart Fail. 2024 Jun;11(3):1758-1766. doi: 10.1002/ehf2.14734. Epub 2024 Mar 8. ESC Heart Fail. 2024. PMID: 38454876 Free PMC article.
β-blockers may be detrimental in frail patients with heart failure with preserved ejection fraction.
Hikoso S, Kida H, Sunaga A, Nakatani D, Okada K, Dohi T, Sotomi Y, Oeun B, Sato T, Matsuoka Y, Kitamura T, Yamada T, Kurakami H, Tamaki S, Seo M, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Yamada T, Yasumura Y, Sakata Y; OCVC-Heart Failure investigators. Hikoso S, et al. Among authors: nakatani d. Clin Res Cardiol. 2024 Jun;113(6):842-855. doi: 10.1007/s00392-023-02301-5. Epub 2023 Nov 29. Clin Res Cardiol. 2024. PMID: 38019285
Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
Sunaga A, Matsuoka Y, Nakatani D, Okada K, Kida H, Sakamoto D, Kitamura T, Tanaka N, Masuda M, Watanabe T, Minamiguchi H, Egami Y, Oka T, Miyoshi M, Okada M, Matsuda Y, Kawasaki M, Inoue K, Hikoso S, Sotomi Y, Sakata Y; OCVC-Arrhythmia Investigators. Sunaga A, et al. Among authors: nakatani d. Int J Cardiol. 2024 Sep 1;410:132231. doi: 10.1016/j.ijcard.2024.132231. Epub 2024 Jun 3. Int J Cardiol. 2024. PMID: 38838745 Free article. Clinical Trial.
Duration of atrial fibrillation persistence: Implications for recurrence risk after catheter ablation and efficacy of additional substrate ablation.
Matsunaga-Lee Y, Inoue K, Tanaka N, Masuda M, Watanabe T, Makino N, Egami Y, Oka T, Minamiguchi H, Miyoshi M, Okada M, Kanda T, Matsuda Y, Kawasaki M, Kawanami S, Ukita K, Kawamura A, Yasumoto K, Tsuda M, Okamoto N, Yano M, Nishino M, Sunaga A, Sotomi Y, Dohi T, Nakatani D, Hikoso S, Sakata Y; Osaka Cardiovascular Conference (OCVC)–Arrhythmia Investigators. Matsunaga-Lee Y, et al. Among authors: nakatani d. Heart Rhythm. 2024 Jun;21(6):733-740. doi: 10.1016/j.hrthm.2024.01.053. Epub 2024 Feb 1. Heart Rhythm. 2024. PMID: 38307310 Clinical Trial.
Long-Term Impact of Additional Ablation After Pulmonary Vein Isolation: Results From EARNEST-PVI Trial.
Masuda M, Inoue K, Tanaka N, Watanabe T, Makino N, Egami Y, Oka T, Minamiguchi H, Miyoshi M, Okada M, Kanda T, Mano T, Matsuda Y, Uematsu H, Sakio T, Kawasaki M, Sunaga A, Sotomi Y, Dohi T, Nakatani D, Hikoso S, Sakata Y; Osaka Cardiovascular Conference (OCVC)‐Arrhythmia Investigators. Masuda M, et al. Among authors: nakatani d. J Am Heart Assoc. 2023 Sep 5;12(17):e029651. doi: 10.1161/JAHA.123.029651. Epub 2023 Aug 29. J Am Heart Assoc. 2023. PMID: 37642022 Free PMC article. Clinical Trial.
The WATCH-DM risk score estimates clinical outcomes in type 2 diabetic patients with heart failure with preserved ejection fraction.
Iwakura K, Onishi T, Okamura A, Koyama Y, Tanaka N, Okada M, Fujii K, Seo M, Yamada T, Yano M, Hayashi T, Yasumura Y, Nakagawa Y, Tamaki S, Nakagawa A, Sotomi Y, Hikoso S, Nakatani D, Sakata Y; PURSUIT-HFpEF Investigators. Iwakura K, et al. Among authors: nakatani d. Sci Rep. 2024 Jan 19;14(1):1746. doi: 10.1038/s41598-024-52101-8. Sci Rep. 2024. PMID: 38243047 Free PMC article.
175 results